Investor Type
Michael Kaufman, CEO of MAK Capital
Announced Date | Organization Name | Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|---|---|
obfuscated obfuscation | Noveome Biotherapeutics | MAK Capital | Series E - Noveome Biotherapeutics | obfuscated obfuscation |